-
NEW DELHI: UGC launches common faculty recruitment portal for central universities. - May 4, 2023
-
LONDON: KL Rahul, Jaydev Unadkat ruled out of IPL 2023, in danger of missing WTC final for India. - May 4, 2023
-
GENEVA: World should prepare for El Nino, new record temperatures: UN. - May 3, 2023
-
WASHINGTON: US philanthropy platform raises over $1 million for 25 Indian NGOs with help of young Indian-Americans. - May 3, 2023
-
MOSCOW: India’s Urals oil imports dip in April as China ups competition. - May 2, 2023
-
CUPERTINO: Apple opens its first retail store in India. - May 2, 2023
-
KHARTOUM: Operation Kaveri, India brings home 754 more citizens from Sudan. - May 1, 2023
-
BAHRAIN: Visit of MOS Shri. V. Muraleedharan,to Saudi Arabia & Bahrain. - May 1, 2023
-
CALIFORNIA: Google took action against over 3,500 loan apps in India for violating norms in 2022. - April 28, 2023
-
SAN JOSE: Startup with Indian roots beats Nvidia at ML Olympics. - April 26, 2023
BANJUL : India offers support for Africa to fight the Omicron variant
BANJUL : We have noted the emergence of a new variant of Covid-19, Omicron. We express our solidarity with the countries, particularly in Africa, who have so far been affected by the Omicron variant.
The Government of India stands ready to support the countries affected in Africa in dealing with the Omicron variant, including by supplies of Made-in-India vaccines. Supplies can be undertaken through COVAX or bilaterally. In this regard, the Government has cleared all orders placed so far by COVAX for supplies of COVISHIELD vaccines including to African countries like Malawi, Ethiopia, Zambia, Mozambique, Guinea and Lesotho. We have also cleared supplies of COVAXIN to Botswana. Any new requirement projected either bilaterally or through COVAX will be considered expeditiously.
India also stands ready to supply essential life-saving drugs, test kits, gloves, PPE kits and medical equipment such as ventilators, as may be required. Indian institutions would favourably consider cooperation in genomic surveillance and virus characterization related research work with their African counterparts.
India has, so far, supplied more than 25 million doses of Made-in-India vaccines to 41 countries in Africa, including nearly 1 million doses as grant to 16 countries and more than 16 million doses under the COVAX facility to 33 countries.]